Biomarker is constantly evolving as the latent for the development of innovative drugs and diagnostic assays for early detection of disease. The major developments are witnessed in immune therapies where breakthroughs will be appearing soon.
The 4th Annual Biomarker and Companion Diagnostics Conference scheduled to be held on 7th-8th February 2019 in San Diego, CA would address the gaps between early stage biomarker development and the commercialization stage of biomarkers. Regarding commercialization of biomarkers, leading industry and academic experts would share their case studies focusing on advancements in the companion diagnostics area. The keynote presentations would also help the attendees understand the issues related to clinical translation of biomarkers.
We also have a UK Edition which will be held on 3 - 4 October 2019. View more details about the conference here.
We will soon be announcing the Dates and Venue for the 5th Biomarker and Companion Diagnostics Conference 2020. Email us on [email protected] to book your place at the conference.
Investigator, Biomarker Expert , Novartis
Head, Proteogenomics , Genzyme Sanofi
Scientific Director , Janssen Research & Development
Director of Bioinformatics and Data Science , CareDx
Senior Scientist , AbCam
Senior Medical Science Director, ACT Genomics
Senior Vice President and Chief Scientific Officer , Singulex
Senior Director, Research and Business Development , Adaptive Biotechnologies
Head, Business Development , Asuragen
CEO , BioFluidica
Senior Key Account and Business Development Manager , Becton Dickinson
Chief Medical Officer , Ambry Genetics
Senior Director of Business Development, Oxford BioDynamics
CEO, CSO , Invivoscribe
The Westin San Diego Gaslamp Quarter 910 Broadway Cir, San Diego, CA 92101, USA